XAGE
Longevity Health Holdings, Inc.Company with tickers: XAGE, XAGEW
CIK
1842939
CUSIP
142922129
Shares Outstanding
2,475,321
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $510,353 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | $269,823 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $1,776,574 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $196,912 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-1,506,751 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-1,505,867 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-1.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-1.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |